The role of BAFF and APRIL in rheumatoid arthritis-Reference-Cited by-同舟云学术

The role of BAFF and APRIL in rheumatoid arthritis

Published:2019-04-02 Issue:10 Volume:234 Page:17050-17063
ISSN:0021-9541
Container-title:Journal of Cellular Physiology
language:en
Short-container-title:J Cell Physiol

Author:

Shabgah Arezoo G.¹^ORCID,Shariati‐Sarabi Zhaleh²,Tavakkol‐Afshari Jalil¹,Mohammadi Mojgan¹³^ORCID

Affiliation:

1. Immunology Research Center Mashhad University of Medical Sciences Mashhad Iran

2. Rheumatic Diseases Research Center Mashhad University of Medical Sciences Mashhad Iran

3. Allergy Research Center Mashhad University of Medical Sciences Mashhad Iran

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcp.28445

Reference143 articles.

1. One year in review 2017: Pathogenesis of rheumatoid arthritis;Angelotti F.;Clinical and Experimental Rheumatology,2017

2. APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells

3. Concentrations of BAFF correlate with autoantibody levels, clinical disease activity, and response to treatment in early rheumatoid arthritis;Bosello S.;The Journal of Rheumatology,2008

4. TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Telitacicept: A novel horizon in targeting autoimmunity and rheumatic diseases;Journal of Autoimmunity;2024-09

2. Immune cell-mediated features of atherosclerosis;Frontiers in Cardiovascular Medicine;2024-08-21

3. Serum BAFF levels are associated with the prognosis of idiopathic membranous nephropathy;Renal Failure;2024-08-14

4. A multicenter, randomized, open‐label, phase 2 clinical study of telitacicept in adult patients with generalized myasthenia gravis;European Journal of Neurology;2024-05-10

5. Drugs in Development to Treat IgA Nephropathy;Drugs;2024-05